<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:9e8efd3a-9b0e-4bca-8dbf-a0b82498c41f,g:a6bf786c-d4f4-4a93-89ae-0749795056b9,d:b193d0b733ef4fdd8e08606505a32826--><html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>mgnx-20220522</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i9a0d481cea7e4575b539c2435ea4650f_D20220522-20220522" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmIxOTNkMGI3MzNlZjRmZGQ4ZTA4NjA2NTA1YTMyODI2L3NlYzpiMTkzZDBiNzMzZWY0ZmRkOGUwODYwNjUwNWEzMjgyNl80L2ZyYWc6YWZiYTVhMWU5N2EwNGNkZTg1OWVmYjM0MjRiOWEyZDIvdGFibGU6Y2FkYTNmNTlhNjMzNDU0ZmJmZmQwMDhkM2M0NDI4NmIvdGFibGVyYW5nZTpjYWRhM2Y1OWE2MzM0NTRmYmZmZDAwOGQzYzQ0Mjg2Yl8yLTEtMS0xLTQ2MjEw_97e73145-392e-4155-83c4-f7b0423e79a5">0001125345</ix:nonNumeric><ix:nonNumeric contextRef="i9a0d481cea7e4575b539c2435ea4650f_D20220522-20220522" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmIxOTNkMGI3MzNlZjRmZGQ4ZTA4NjA2NTA1YTMyODI2L3NlYzpiMTkzZDBiNzMzZWY0ZmRkOGUwODYwNjUwNWEzMjgyNl80L2ZyYWc6YWZiYTVhMWU5N2EwNGNkZTg1OWVmYjM0MjRiOWEyZDIvdGFibGU6Y2FkYTNmNTlhNjMzNDU0ZmJmZmQwMDhkM2M0NDI4NmIvdGFibGVyYW5nZTpjYWRhM2Y1OWE2MzM0NTRmYmZmZDAwOGQzYzQ0Mjg2Yl8zLTEtMS0xLTQ2MjEw_1559f5bf-0e49-48d4-be92-99dc7fd2e78b">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="mgnx-20220522.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i9a0d481cea7e4575b539c2435ea4650f_D20220522-20220522"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125345</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-22</xbrli:startDate><xbrli:endDate>2022-05-22</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ib193d0b733ef4fdd8e08606505a32826_1"></div><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i9a0d481cea7e4575b539c2435ea4650f_D20220522-20220522" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmIxOTNkMGI3MzNlZjRmZGQ4ZTA4NjA2NTA1YTMyODI2L3NlYzpiMTkzZDBiNzMzZWY0ZmRkOGUwODYwNjUwNWEzMjgyNl8xL2ZyYWc6YzJhYjg4MWVmOTZmNDM5Yjg3MTM0NjBlYjBkNTk3MjQvdGV4dHJlZ2lvbjpjMmFiODgxZWY5NmY0MzliODcxMzQ2MGViMGQ1OTcyNF8xNjQ3_20ff5826-a2be-43c9-93fb-d97907113477">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Pursuant to Section 13 or 15(d) of the</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities Exchange Act of 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of report (Date of earliest event reported):&#160; <ix:nonNumeric contextRef="i9a0d481cea7e4575b539c2435ea4650f_D20220522-20220522" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmIxOTNkMGI3MzNlZjRmZGQ4ZTA4NjA2NTA1YTMyODI2L3NlYzpiMTkzZDBiNzMzZWY0ZmRkOGUwODYwNjUwNWEzMjgyNl8xL2ZyYWc6YzJhYjg4MWVmOTZmNDM5Yjg3MTM0NjBlYjBkNTk3MjQvdGV4dHJlZ2lvbjpjMmFiODgxZWY5NmY0MzliODcxMzQ2MGViMGQ1OTcyNF8yMzI_fcf9a074-25aa-4ed6-b4c7-520aa5f843d7">May 22, 2022</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9a0d481cea7e4575b539c2435ea4650f_D20220522-20220522" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmIxOTNkMGI3MzNlZjRmZGQ4ZTA4NjA2NTA1YTMyODI2L3NlYzpiMTkzZDBiNzMzZWY0ZmRkOGUwODYwNjUwNWEzMjgyNl8xL2ZyYWc6YzJhYjg4MWVmOTZmNDM5Yjg3MTM0NjBlYjBkNTk3MjQvdGV4dHJlZ2lvbjpjMmFiODgxZWY5NmY0MzliODcxMzQ2MGViMGQ1OTcyNF8xNjQy_c364d279-68ed-4365-b558-0601c3553c39">MACROGENICS, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> (Exact Name of Registrant as Specified in Charter)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.948%"><tr><td style="width:1.0%"></td><td style="width:18.210%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.037%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.244%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.968%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.244%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.697%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9a0d481cea7e4575b539c2435ea4650f_D20220522-20220522" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmIxOTNkMGI3MzNlZjRmZGQ4ZTA4NjA2NTA1YTMyODI2L3NlYzpiMTkzZDBiNzMzZWY0ZmRkOGUwODYwNjUwNWEzMjgyNl8xL2ZyYWc6YzJhYjg4MWVmOTZmNDM5Yjg3MTM0NjBlYjBkNTk3MjQvdGFibGU6ZDI4MTQ2YWNlNGRkNDVmNTkzOWYwM2MzYjFjMzk0ZTAvdGFibGVyYW5nZTpkMjgxNDZhY2U0ZGQ0NWY1OTM5ZjAzYzNiMWMzOTRlMF8wLTAtMS0xLTQ2MjEw_a100274d-f2c8-4599-9e69-dd1709652079">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9a0d481cea7e4575b539c2435ea4650f_D20220522-20220522" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmIxOTNkMGI3MzNlZjRmZGQ4ZTA4NjA2NTA1YTMyODI2L3NlYzpiMTkzZDBiNzMzZWY0ZmRkOGUwODYwNjUwNWEzMjgyNl8xL2ZyYWc6YzJhYjg4MWVmOTZmNDM5Yjg3MTM0NjBlYjBkNTk3MjQvdGFibGU6ZDI4MTQ2YWNlNGRkNDVmNTkzOWYwM2MzYjFjMzk0ZTAvdGFibGVyYW5nZTpkMjgxNDZhY2U0ZGQ0NWY1OTM5ZjAzYzNiMWMzOTRlMF8wLTMtMS0xLTQ2MjEw_19c1c659-2ab2-4c09-8191-f003cde76477">001-36112</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9a0d481cea7e4575b539c2435ea4650f_D20220522-20220522" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmIxOTNkMGI3MzNlZjRmZGQ4ZTA4NjA2NTA1YTMyODI2L3NlYzpiMTkzZDBiNzMzZWY0ZmRkOGUwODYwNjUwNWEzMjgyNl8xL2ZyYWc6YzJhYjg4MWVmOTZmNDM5Yjg3MTM0NjBlYjBkNTk3MjQvdGFibGU6ZDI4MTQ2YWNlNGRkNDVmNTkzOWYwM2MzYjFjMzk0ZTAvdGFibGVyYW5nZTpkMjgxNDZhY2U0ZGQ0NWY1OTM5ZjAzYzNiMWMzOTRlMF8wLTUtMS0xLTQ2MjEw_9e2f0595-9447-4d40-a1c3-a63415934871">06-1591613</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(State or Other Jurisdiction of Incorporation)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Commission<br/>File Number)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(IRS Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;Identification No.)</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9a0d481cea7e4575b539c2435ea4650f_D20220522-20220522" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmIxOTNkMGI3MzNlZjRmZGQ4ZTA4NjA2NTA1YTMyODI2L3NlYzpiMTkzZDBiNzMzZWY0ZmRkOGUwODYwNjUwNWEzMjgyNl8xL2ZyYWc6YzJhYjg4MWVmOTZmNDM5Yjg3MTM0NjBlYjBkNTk3MjQvdGFibGU6ZDI4MTQ2YWNlNGRkNDVmNTkzOWYwM2MzYjFjMzk0ZTAvdGFibGVyYW5nZTpkMjgxNDZhY2U0ZGQ0NWY1OTM5ZjAzYzNiMWMzOTRlMF8zLTAtMS0xLTQ2MjEw_75c22d99-44c4-49c2-a757-126385d37021">9704 Medical Center Drive</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9a0d481cea7e4575b539c2435ea4650f_D20220522-20220522" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmIxOTNkMGI3MzNlZjRmZGQ4ZTA4NjA2NTA1YTMyODI2L3NlYzpiMTkzZDBiNzMzZWY0ZmRkOGUwODYwNjUwNWEzMjgyNl8xL2ZyYWc6YzJhYjg4MWVmOTZmNDM5Yjg3MTM0NjBlYjBkNTk3MjQvdGFibGU6ZDI4MTQ2YWNlNGRkNDVmNTkzOWYwM2MzYjFjMzk0ZTAvdGFibGVyYW5nZTpkMjgxNDZhY2U0ZGQ0NWY1OTM5ZjAzYzNiMWMzOTRlMF80LTAtMS0xLTQ2MjEw_043e399e-446f-4817-a208-b576e939e58b">Rockville,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9a0d481cea7e4575b539c2435ea4650f_D20220522-20220522" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmIxOTNkMGI3MzNlZjRmZGQ4ZTA4NjA2NTA1YTMyODI2L3NlYzpiMTkzZDBiNzMzZWY0ZmRkOGUwODYwNjUwNWEzMjgyNl8xL2ZyYWc6YzJhYjg4MWVmOTZmNDM5Yjg3MTM0NjBlYjBkNTk3MjQvdGFibGU6ZDI4MTQ2YWNlNGRkNDVmNTkzOWYwM2MzYjFjMzk0ZTAvdGFibGVyYW5nZTpkMjgxNDZhY2U0ZGQ0NWY1OTM5ZjAzYzNiMWMzOTRlMF80LTEtMS0xLTQ2MjEw_19eaa976-07f8-4ce5-8742-56d422054986">Maryland</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9a0d481cea7e4575b539c2435ea4650f_D20220522-20220522" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmIxOTNkMGI3MzNlZjRmZGQ4ZTA4NjA2NTA1YTMyODI2L3NlYzpiMTkzZDBiNzMzZWY0ZmRkOGUwODYwNjUwNWEzMjgyNl8xL2ZyYWc6YzJhYjg4MWVmOTZmNDM5Yjg3MTM0NjBlYjBkNTk3MjQvdGFibGU6ZDI4MTQ2YWNlNGRkNDVmNTkzOWYwM2MzYjFjMzk0ZTAvdGFibGVyYW5nZTpkMjgxNDZhY2U0ZGQ0NWY1OTM5ZjAzYzNiMWMzOTRlMF80LTMtMS0xLTQ2MjEw_0b0c6be7-c116-4f82-b4aa-6e0b3adad3f5">20850</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Address of Principal Executive Offices)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant's telephone number, including area code:&#160; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i9a0d481cea7e4575b539c2435ea4650f_D20220522-20220522" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmIxOTNkMGI3MzNlZjRmZGQ4ZTA4NjA2NTA1YTMyODI2L3NlYzpiMTkzZDBiNzMzZWY0ZmRkOGUwODYwNjUwNWEzMjgyNl8xL2ZyYWc6YzJhYjg4MWVmOTZmNDM5Yjg3MTM0NjBlYjBkNTk3MjQvdGV4dHJlZ2lvbjpjMmFiODgxZWY5NmY0MzliODcxMzQ2MGViMGQ1OTcyNF8xNjQ4_49505a01-061d-420e-b85f-13a51b01600f">301</ix:nonNumeric>) <ix:nonNumeric contextRef="i9a0d481cea7e4575b539c2435ea4650f_D20220522-20220522" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmIxOTNkMGI3MzNlZjRmZGQ4ZTA4NjA2NTA1YTMyODI2L3NlYzpiMTkzZDBiNzMzZWY0ZmRkOGUwODYwNjUwNWEzMjgyNl8xL2ZyYWc6YzJhYjg4MWVmOTZmNDM5Yjg3MTM0NjBlYjBkNTk3MjQvdGV4dHJlZ2lvbjpjMmFiODgxZWY5NmY0MzliODcxMzQ2MGViMGQ1OTcyNF8xNjQ5_1ae18e7c-3de3-4cd7-aa07-2a4476cb512f">251-5172</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Not applicable&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Former Name or Former Address, if Changed Since Last Report)</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:9pt;padding-right:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9a0d481cea7e4575b539c2435ea4650f_D20220522-20220522" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmIxOTNkMGI3MzNlZjRmZGQ4ZTA4NjA2NTA1YTMyODI2L3NlYzpiMTkzZDBiNzMzZWY0ZmRkOGUwODYwNjUwNWEzMjgyNl8xL2ZyYWc6YzJhYjg4MWVmOTZmNDM5Yjg3MTM0NjBlYjBkNTk3MjQvdGFibGU6Yzc4YjE3NTQxNjgzNDNkODhkMWU5ZjM3MDgzZTBkZWUvdGFibGVyYW5nZTpjNzhiMTc1NDE2ODM0M2Q4OGQxZTlmMzcwODNlMGRlZV8xLTAtMS0xLTQ2MjEw_71353275-67d3-43b2-a34a-ffad05d748c3">Common Stock, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9a0d481cea7e4575b539c2435ea4650f_D20220522-20220522" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmIxOTNkMGI3MzNlZjRmZGQ4ZTA4NjA2NTA1YTMyODI2L3NlYzpiMTkzZDBiNzMzZWY0ZmRkOGUwODYwNjUwNWEzMjgyNl8xL2ZyYWc6YzJhYjg4MWVmOTZmNDM5Yjg3MTM0NjBlYjBkNTk3MjQvdGFibGU6Yzc4YjE3NTQxNjgzNDNkODhkMWU5ZjM3MDgzZTBkZWUvdGFibGVyYW5nZTpjNzhiMTc1NDE2ODM0M2Q4OGQxZTlmMzcwODNlMGRlZV8xLTEtMS0xLTQ2MjEw_dd233673-08d0-49c8-aa6e-61c943d2edd1">MGNX</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9a0d481cea7e4575b539c2435ea4650f_D20220522-20220522" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmIxOTNkMGI3MzNlZjRmZGQ4ZTA4NjA2NTA1YTMyODI2L3NlYzpiMTkzZDBiNzMzZWY0ZmRkOGUwODYwNjUwNWEzMjgyNl8xL2ZyYWc6YzJhYjg4MWVmOTZmNDM5Yjg3MTM0NjBlYjBkNTk3MjQvdGFibGU6Yzc4YjE3NTQxNjgzNDNkODhkMWU5ZjM3MDgzZTBkZWUvdGFibGVyYW5nZTpjNzhiMTc1NDE2ODM0M2Q4OGQxZTlmMzcwODNlMGRlZV8xLTItMS0xLTQ2MjEw_68447465-79c9-4fd7-8af6-f5e4b180cf82">Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:5.25pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></div><div style="margin-bottom:3pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9a0d481cea7e4575b539c2435ea4650f_D20220522-20220522" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmIxOTNkMGI3MzNlZjRmZGQ4ZTA4NjA2NTA1YTMyODI2L3NlYzpiMTkzZDBiNzMzZWY0ZmRkOGUwODYwNjUwNWEzMjgyNl8xL2ZyYWc6YzJhYjg4MWVmOTZmNDM5Yjg3MTM0NjBlYjBkNTk3MjQvdGV4dHJlZ2lvbjpjMmFiODgxZWY5NmY0MzliODcxMzQ2MGViMGQ1OTcyNF8xNjUw_57480c6c-4f40-4f33-bfae-6ecaa264ffce">&#9744;</ix:nonNumeric> Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</span></div><div style="margin-bottom:3pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9a0d481cea7e4575b539c2435ea4650f_D20220522-20220522" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmIxOTNkMGI3MzNlZjRmZGQ4ZTA4NjA2NTA1YTMyODI2L3NlYzpiMTkzZDBiNzMzZWY0ZmRkOGUwODYwNjUwNWEzMjgyNl8xL2ZyYWc6YzJhYjg4MWVmOTZmNDM5Yjg3MTM0NjBlYjBkNTk3MjQvdGV4dHJlZ2lvbjpjMmFiODgxZWY5NmY0MzliODcxMzQ2MGViMGQ1OTcyNF8xNjQ2_7a61fb1e-0989-4d8f-91df-40303a1f72c1">&#9744;</ix:nonNumeric> Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="margin-bottom:3pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9a0d481cea7e4575b539c2435ea4650f_D20220522-20220522" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmIxOTNkMGI3MzNlZjRmZGQ4ZTA4NjA2NTA1YTMyODI2L3NlYzpiMTkzZDBiNzMzZWY0ZmRkOGUwODYwNjUwNWEzMjgyNl8xL2ZyYWc6YzJhYjg4MWVmOTZmNDM5Yjg3MTM0NjBlYjBkNTk3MjQvdGV4dHJlZ2lvbjpjMmFiODgxZWY5NmY0MzliODcxMzQ2MGViMGQ1OTcyNF8xNjQz_e0ea38ee-2517-42eb-913a-cbc1fca54105">&#9744;</ix:nonNumeric> Pre-commencement communications pursuant to Rule&#160;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9a0d481cea7e4575b539c2435ea4650f_D20220522-20220522" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmIxOTNkMGI3MzNlZjRmZGQ4ZTA4NjA2NTA1YTMyODI2L3NlYzpiMTkzZDBiNzMzZWY0ZmRkOGUwODYwNjUwNWEzMjgyNl8xL2ZyYWc6YzJhYjg4MWVmOTZmNDM5Yjg3MTM0NjBlYjBkNTk3MjQvdGV4dHJlZ2lvbjpjMmFiODgxZWY5NmY0MzliODcxMzQ2MGViMGQ1OTcyNF8xNjQ0_1a3d681f-5d27-424a-9e06-386fe152b620">&#9744;</ix:nonNumeric> Pre-commencement communications pursuant to Rule&#160;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). </span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company  <ix:nonNumeric contextRef="i9a0d481cea7e4575b539c2435ea4650f_D20220522-20220522" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmIxOTNkMGI3MzNlZjRmZGQ4ZTA4NjA2NTA1YTMyODI2L3NlYzpiMTkzZDBiNzMzZWY0ZmRkOGUwODYwNjUwNWEzMjgyNl8xL2ZyYWc6YzJhYjg4MWVmOTZmNDM5Yjg3MTM0NjBlYjBkNTk3MjQvdGV4dHJlZ2lvbjpjMmFiODgxZWY5NmY0MzliODcxMzQ2MGViMGQ1OTcyNF8xNjQ1_79f4724a-6c8c-4979-8e4d-9ed1963bc968">&#9744;</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   &#9744;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ib193d0b733ef4fdd8e08606505a32826_7"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Item 5.02</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</span></div><div><span><br/></span></div></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On <ix:nonNumeric contextRef="i9a0d481cea7e4575b539c2435ea4650f_D20220522-20220522" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmIxOTNkMGI3MzNlZjRmZGQ4ZTA4NjA2NTA1YTMyODI2L3NlYzpiMTkzZDBiNzMzZWY0ZmRkOGUwODYwNjUwNWEzMjgyNl83L2ZyYWc6MWFkYjg2ZGVjYzUzNDI0N2E4YWI0ZDlkM2M4NzZkMzAvdGV4dHJlZ2lvbjoxYWRiODZkZWNjNTM0MjQ3YThhYjRkOWQzYzg3NmQzMF8xMDk5NTExNjI5Njgy_fcf9a074-25aa-4ed6-b4c7-520aa5f843d7">May&#160;22, 2022</ix:nonNumeric>, the Board of Directors (the "Board") of MacroGenics, Inc. (the "Company") approved the appointment of William K. Heiden to serve as a director on the Board, effective immediately. Mr. Heiden has been designated as a Class III director to hold office until the Company&#8217;s 2025 Annual Meeting of Stockholders, or until his successor has been duly elected and qualified, or until his earlier death, resignation or removal. Mr. Heiden has been appointed to serve as non-executive Chair of the Board, effective immediately, replacing Mr. Paulo Costa, who served in such position until his term as a director expired on May 19, 2022 upon the conclusion of the 2022 Annual Meeting of Stockholders (the &#8220;Annual Meeting&#8221;). Mr. Heiden has also been appointed to the Audit Committee of the Board, effective immediately. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consistent with the Company's Director Compensation Program for non-employee directors, as described under the heading "Director Compensation" in the Company's most recent proxy statement filed with the Securities and Exchange Commission on April 8, 2022, Mr. Heiden will receive an annual retainer as compensation for his service.   In addition, upon appointment to the Board, Mr. Heiden has been granted an option to purchase 36,000 shares of the Company's common stock at an exercise price of $3.96 per share, the closing market price of the Company's common stock on the date of grant, and vesting in thirty six (36) substantially equal monthly portions beginning on the first monthly anniversary of the date of grant, subject to Mr. Heiden&#8217;s continued service on the Board through each vesting date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no arrangements or understandings between Mr. Heiden and any other person pursuant to which Mr. Heiden was selected as a director, and there are no transactions in which the Company is a party and in which Mr. Heiden has a material interest subject to disclosure under Item 404(a) of Regulation S-K.</span></div><div><span><br/></span></div><div id="ib193d0b733ef4fdd8e08606505a32826_54"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:55.128%"><tr><td style="width:1.0%"></td><td style="width:25.934%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:71.866%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Item 7.01</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Regulation FD Disclosure.</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 23, 2022, the Company issued a press release (the &#8220;Press Release&#8221;) announcing the appointment of Mr. Heiden to the Board. A copy of the Press Release is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information in this Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, is being furnished pursuant to Item 7.01 and shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, except as expressly set forth by specific reference in such filing to this item of this report.</span></div><div style="margin-bottom:6pt"><span><br/></span></div><div id="ib193d0b733ef4fdd8e08606505a32826_10"></div><div style="-sec-extract:summary"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.358%"><tr><td style="width:1.0%"></td><td style="width:16.158%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.642%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Item 9.01</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Financial Statements and Exhibits</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(d)     Exhibits.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Description of Exhibit</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit99-1heidenappt52322.htm">99.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit99-1heidenappt52322.htm">Press Release, dated May 23, 2022.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data (embedded within the Inline XBRL document).</span></td></tr></table></div><div><span><br/></span></div><div id="ib193d0b733ef4fdd8e08606505a32826_13"></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURE</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.032%"><tr><td style="width:1.0%"></td><td style="width:44.937%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.488%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.275%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MACROGENICS, INC.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:  May 24, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">/s/ Jeffrey Peters</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jeffrey Peters</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President and General Counsel</span></div></td></tr></table></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
[{"type": "8-K", "sequence": "1", "filename": "mgnx-20220522.htm", "description": "8-K", "secsgml_size_bytes": 37975}]
{"company-data": {"conformed-name": "MACROGENICS INC", "cik": "0001125345", "assigned-sic": "2834", "irs-number": "000000000", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-36112", "film-number": "22954086"}, "business-address": {"street1": "9704 MEDICAL CENTER DRIVE", "city": "Rockville", "state": "MD", "zip": "20850", "phone": "301-251-5172"}, "mail-address": {"street1": "9704 MEDICAL CENTER DRIVE", "city": "ROCKVILLE", "state": "MD", "zip": "20850"}}
mgnx-20220522
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported):
May 22, 2022
MACROGENICS, INC.
(Exact Name of Registrant as Specified in Charter)
Delaware
001-36112
06-1591613
(State or Other Jurisdiction of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
9704 Medical Center Drive
Rockville,
Maryland
20850
(Address of Principal Executive Offices)
(Zip Code)
Registrant's telephone number, including area code:
(
301
)
251-5172
Not applicable
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.01 per share
MGNX
Nasdaq Global Select Market
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On
May 22, 2022
, the Board of Directors (the "Board") of MacroGenics, Inc. (the "Company") approved the appointment of William K. Heiden to serve as a director on the Board, effective immediately. Mr. Heiden has been designated as a Class III director to hold office until the Company's 2025 Annual Meeting of Stockholders, or until his successor has been duly elected and qualified, or until his earlier death, resignation or removal. Mr. Heiden has been appointed to serve as non-executive Chair of the Board, effective immediately, replacing Mr. Paulo Costa, who served in such position until his term as a director expired on May 19, 2022 upon the conclusion of the 2022 Annual Meeting of Stockholders (the "Annual Meeting"). Mr. Heiden has also been appointed to the Audit Committee of the Board, effective immediately.
Consistent with the Company's Director Compensation Program for non-employee directors, as described under the heading "Director Compensation" in the Company's most recent proxy statement filed with the Securities and Exchange Commission on April 8, 2022, Mr. Heiden will receive an annual retainer as compensation for his service.   In addition, upon appointment to the Board, Mr. Heiden has been granted an option to purchase 36,000 shares of the Company's common stock at an exercise price of $3.96 per share, the closing market price of the Company's common stock on the date of grant, and vesting in thirty six (36) substantially equal monthly portions beginning on the first monthly anniversary of the date of grant, subject to Mr. Heiden's continued service on the Board through each vesting date.
There are no arrangements or understandings between Mr. Heiden and any other person pursuant to which Mr. Heiden was selected as a director, and there are no transactions in which the Company is a party and in which Mr. Heiden has a material interest subject to disclosure under Item 404(a) of Regulation S-K.
Item 7.01
Regulation FD Disclosure.
On May 23, 2022, the Company issued a press release (the "Press Release") announcing the appointment of Mr. Heiden to the Board. A copy of the Press Release is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K.
The information in this Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, is being furnished pursuant to Item 7.01 and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, except as expressly set forth by specific reference in such filing to this item of this report.
Item 9.01
Financial Statements and Exhibits
(d)     Exhibits.
Exhibit Number
Description of Exhibit
99.1
Press Release, dated May 23, 2022.
104
Cover Page Interactive Data (embedded within the Inline XBRL document).
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
MACROGENICS, INC.
Date:  May 24, 2022
By:
Name:
Title:
/s/ Jeffrey Peters
Jeffrey Peters
Vice President and General Counsel